$15M allocated to AIDS vaccine research

August 2, 2007

A U.S. scientist who co-discovered the virus that causes AIDS will use a $15 million grant to develop a potential vaccine.

Dr. Robert Gallo of the University of Maryland said at a news conference that he will use the five-year grant from the Bill and Melinda Gates Foundation to test a vaccine that could potentially eliminate the virus in already infected cells, The Washington Times said Wednesday.

The vaccine has been tested successfully on monkeys.

The grant is part of the Gates Foundation's Collaboration for AIDS Vaccine Discovery, which started last year with $287 million in grants.

Gallo has a public-private partnership with Wyeth Pharmaceuticals and Profectus BioSciences, a spinoff of the university's Institute of Human Virology, the newspaper said.

Copyright 2007 by United Press International

Explore further: Refugee and migrant women require additional sexual and reproductive health support

Related Stories

Refugee and migrant women require additional sexual and reproductive health support

August 15, 2017
A Western Sydney University report has revealed that a cycle of misinformation, shyness and fear is preventing migrant and refugee women from receiving adequate sexual and reproductive health care and support.

SA child living with HIV maintains remission without ARVs since 2008

July 26, 2017
Dr Avy Violari, head of pediatric research at the Perinatal HIV Research Unit (PHRU) in the Faculty of Health Sciences, University of the Witwatersrand, reported the case on 25 July 2017 at the 9th International AIDS Society ...

Persistence yields progress in AIDS vaccine research

May 14, 2015
Phil Berman has been working to develop an AIDS vaccine for nearly 30 years, first at the pioneering biotech company Genentech, then as cofounder of VaxGen, and now at UC Santa Cruz, where he is the Baskin Professor of Biomolecular ...

AIDS research team in US loses $1.38M grant (Update)

July 8, 2014
An AIDS research team at Iowa State University will not get the final $1.38 million payment of a National Institutes of Health five-year grant after a team member admitted last year to faking research results, the NIH said ...

Gates urges more tools, vaccine to end AIDS

July 23, 2012
AIDS cannot be halted through treatment alone, and more prevention tools, in particular a vaccine, are needed to move seriously toward ending it, philanthropist Bill Gates said Monday.

HIV scientists launch EUR23 million project to develop vaccine

November 2, 2015
A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins today.

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.